D. E. Shaw & Co., Inc. - REPROS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$232,000
-29.1%
239,548
-11.3%
0.00%
Q4 2015$327,000
-60.1%
270,109
+145.0%
0.00%
-100.0%
Q3 2015$819,000
-6.6%
110,239
-10.2%
0.00%0.0%
Q2 2015$877,000
+53.3%
122,723
+84.3%
0.00%0.0%
Q1 2015$572,000
+71.3%
66,581
+98.8%
0.00%
Q4 2014$334,000
-8.5%
33,486
-9.0%
0.00%
Q3 2014$365,000
-76.8%
36,811
-59.6%
0.00%
-100.0%
Q2 2014$1,576,000
-21.6%
91,083
-19.6%
0.00%
-33.3%
Q1 2014$2,010,000
-44.4%
113,310
-42.6%
0.00%
-40.0%
Q4 2013$3,614,000
-19.5%
197,489
+18.0%
0.01%
-28.6%
Q3 2013$4,487,000167,4250.01%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 978,800$1,292,0000.33%
Allegis Investment Advisors, LLC 344,487$455,0000.14%
GENERAL AMERICAN INVESTORS CO INC 589,768$778,0000.08%
Acrospire Investment Management LLC 23,177$31,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 268,130$354,0000.01%
Alambic Investment Management, L.P. 16,091$21,0000.00%
OXFORD ASSET MANAGEMENT LLP 51,359$68,0000.00%
Renaissance Technologies 716,413$946,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$4,0000.00%
Virtu KCG Holdings LLC 45,144$60,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders